Inflammatory myofibroblastic tumors—A retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe

Inflammatory myofibroblastic tumors (IMTs) are a rare subgroup of soft tissue tumors. The outcome of patients with IMT has been reported as favorable when the tumor is completely resected. If surgical resection is not possible, systemic therapy has to be considered. However, the best systemic treatment and response rates are currently unclear.

[1]  Makoto Nishio,et al.  Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  P. Stephens,et al.  STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion , 2015, Journal of Hematology & Oncology.

[3]  P. Stephens,et al.  Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. , 2014, Cancer discovery.

[4]  J. Maris,et al.  Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. , 2013, The Lancet. Oncology.

[5]  M. Hoffman,et al.  Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature , 2013, Oncology letters.

[6]  Z. Tothova,et al.  Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors , 2012, Current opinion in oncology.

[7]  S. Sleijfer,et al.  Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  F. Venuta,et al.  Bilateral simultaneous inflammatory myofibroblastic tumor of the lung with distant metastatic spread. , 2011, Interactive cardiovascular and thoracic surgery.

[9]  Y. Ishikawa,et al.  Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1–ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification , 2011, Clinical Cancer Research.

[10]  Marc Ladanyi,et al.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. , 2010, The New England journal of medicine.

[11]  R. Boldrini,et al.  Inflammatory myofibroblastic tumors in childhood , 2009, Cancer.

[12]  M. Dishop,et al.  Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. , 2009, Archives of pathology & laboratory medicine.

[13]  G. Nielsen.  Enzinger and Weiss's Soft Tissue Tumors: , 2009 .

[14]  A. Look,et al.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy , 2009, Expert review of anticancer therapy.

[15]  John M. Maris,et al.  Identification of ALK as a major familial neuroblastoma predisposition gene , 2008, Nature.

[16]  J. Hornick,et al.  Inflammatory myofibroblastic tumours: where are we now? , 2007, Journal of Clinical Pathology.

[17]  F. Ferrer,et al.  Successful preoperative treatment of pediatric bladder inflammatory myofibroblastic tumor with anti-inflammatory therapy. , 2007, Urology.

[18]  C. Fletcher,et al.  Inflammatory Myofibroblastic Tumor: Comparison of Clinicopathologic, Histologic, and Immunohistochemical Features Including ALK Expression in Atypical and Aggressive Cases , 2007, The American journal of surgical pathology.

[19]  D. Rodeberg,et al.  Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis , 2005, Pediatric blood & cancer.

[20]  A. Kaipainen,et al.  The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study. , 2005, Journal of pediatric surgery.

[21]  W. Sanger,et al.  Pediatric Inflammatory Myofibroblastic Tumor With Late Metastasis to the Lung: Case Report and Review of the Literature , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[22]  C. Fisher,et al.  Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature , 2004, Modern Pathology.

[23]  S. Kilpatrick,et al.  Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature. , 2003, Archives of pathology & laboratory medicine.

[24]  S. Morris,et al.  Anaplastic Lymphoma Kinase (ALK) Expression in the Inflammatory Myofibroblastic Tumor: A Comparative Immunohistochemical Study , 2001, The American journal of surgical pathology.

[25]  P. Sorensen,et al.  The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols , 2001, Sarcoma.

[26]  H. Applebaum,et al.  Treatment of pseudotumors with nonsteroidal antiinflammatory drugs. , 2000, Journal of pediatric surgery.

[27]  S. Skapek,et al.  Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Louis P. Dehner,et al.  Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases , 1995, The American journal of surgical pathology.

[29]  C. Garel,et al.  Interleukin-6 and interleukin-1 beta production in a pediatric plasma cell granuloma of the lung. , 1995, The American journal of surgical pathology.

[30]  F. Enzinger,et al.  Inflammatory Fibrosarcoma of the Mesentery and Retroperitoneum: A Tumor Closely Simulating Inflammatory Pseudotumor , 1991, The American journal of surgical pathology.

[31]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[32]  H. Brunn.  two interesting benign lung tumors of contradictory histopathology ; remarks on necessity for maintaining chest tumor registry , 1939 .

[33]  P. Komminoth,et al.  Pathology and Genetics of Tumours of Soft Tissue and Bone , 2013 .

[34]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.